Clinical Trial Update: An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Clemizole HCl for Lennox-Gastaut syndrome is currently recruiting. The sponsor is Epygenix.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Drugs mentioned

• Clemizole HCl (clemizole hydrochloride)

Snippet

Sponsor: Epygenix | Conditions: Lennox Gastaut Syndrome | Phase 3 | Status: RECRUITING